HSCI iPS Core Facility

The Most Experienced iPS Cell Team in the Nation

 

ipscore.png

In July 2008, the Harvard Stem Cell Institute iPS Core Facility was created to accelerate research in the stem cell field by facilitating the derivation and distribution of induced pluripotent stem cell (iPSC) lines. Disease-specific iPSC lines provide us with an opportunity to study the mechanisms of disease and ultimately to develop new treatments.

In recent years, we have refined the iPS Core to better meet investigator needs. The iPS Core now operates on a fee-for-service basis to provide investigators with customized iPSC derivation and gene editing based on the latest cutting-edge stem cell technologies.

  • We offer three non-integrating technologies (Sendai virus, miRNA and modified mRNA, and episomal vector) for reprogramming a variety of somatic cell types.
  • We offer CRISPR gene editing of hESC or hiPSC lines.
  • The iPS Core also serves as a repository for Harvard ESC lines and both control and disease-specific iPSC lines.

All of these services are available to the global research community.

Check out recent publications using Harvard iPS Core services!

Services